Hemali Phatnani directs the Center for Genomics of Neurodegenerative Disease at the New York Genome Center, holding a joint appointment as Assistant Professor at Columbia University. Her research applies state-of-the-art genomics and bioinformatics to understand diseases like ALS and FTD. She earned her PhD in Biochemistry and Molecular Biology from Duke University.
She established the NYGC ALS Consortium, a major global collaboration that fosters data sharing on an unparalleled scale to accelerate research into new treatments for ALS.
Hemali Phatnani
Co-Director, Center for Genomics of Neurodegenerative Disease at New York Genome Center
New York, New York, United States
Overview
Topics They Care About
ALS Research
Her lab's primary focus is on the spectrum of Amyotrophic Lateral Sclerosis (ALS), applying genomics to understand its pathogenesis and find new treatments.
Scientific Collaboration
She established and directs the NYGC ALS Consortium, a global initiative uniting clinicians, scientists, and industry partners to advance research through data sharing.
Genomic Research
Her work integrates multimodal genomics approaches, including spatial transcriptomics and bioinformatics, to study the molecular basis of disease at the single-cell and tissue level.
Media Appearances
Work History
3-2014
Co-Director, Center for Genomics of Neurodegenerative Disease at New York Genome Center
9-2009
Associate Research Scientist at Columbia University Medical Center
10-2006 - 9-2009
Postdoctoral Fellow at Harvard University
1-2005 - 9-2006
Postdoctoral Research Associate at Duke University Medical Center
Education
1997 - 2004
Education details unavailable from Duke University
More Information
Social Presence :
Prographics :
Exp : 21
Location : New York, New York, United States
Job Level : N/A
Designation : Co-Director, Center for Genomics of Neurodegenerative Disease at New York Genome Center
